BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Capsida Biotherapeutics

Capsida Biotherapeutics logo

Founded
2019

Technologies

Virotherapy

Capsida is a biotechnology company that specializes in tackling monogenetic and sporadic CNS and non-CNS disorders. It features a proprietary adeno-associated virus (AAV) engineering platform that generates capsids optimized to target specific tissues and cells in the diseased organ.

Become a Member to view additional information about this company

Posts Mentioning This Company